Health inspectors have detected rabies in dead bats around Reedley and Fresno, and those bats may have been in contact with ...

SEE ALSO: Community rallies behind beloved Texas Inn server after double amputation Rabies is caused by a virus that attacks the nervous system; it is fatal if proper medical care is not received ...

NGO is demanding that rabies should be classified as an exceptional disease due to its 100% fatality rate and extreme ...

The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

Hummingbirds are a rare sight for some, especially in cities and areas with less vegetation. Luckily, there are a plethora of potted plants that can draw them straight to your doorstep or patio. Check ...

In its plea, All Creatures Great and Small prayed that a procedure should be laid down for rabies patients to allow them or their guardians to opt for the assistance of physicians for assisted ...

Two dogs that were exposed to the virus will be quarantined as required under the South Carolina Rabies Control Act. A nearby feral cat colony was also potentially exposed. An exposure is defined ...

Rabies is rare in Canada, but humans can get infected if they are bitten by an animal with the virus. Symptoms — including confusion, breathing problems and seizures — can show up in two to ...

The demonstration that a little brown bat (probably Myotis lucifugus) that bit a woman in Harvard, Massachusetts, in September, 1961, was infected with rabies virus 5 proved that such infection ...

TORONTO - Health Canada has received more units of the rabies vaccine and expects they will be distributed by the end of the month as Toronto continues to ration its doses amid a shortage.

Fresno County public health officials announced on Friday that animal cases of rabies have been detected. The Fresno County ...

Results from the randomised, open-label clinical trial found a single dose of RBI-4000 prompted an immune response. Credit: Shutterstock / SDV Photography. A Phase I trial of Replicate Bioscience’s ...